Colruyt Group N.V. : An appropriate purchase level
Entry price | Target | Stop-loss | Potential |
---|
€40.11 |
€0 |
€38.9 |
-100% |
---|
In the past few sessions, Colruyt shares have suffered from a sharp fall and is now coming back to a significant level support.
According to Surperformance rating, the company is an opportunity for a trading strategy. Indeed, it is a good compromise between its value and its visibility.
Technically, in daily data, even if moving averages are still in a downtrend, a positive reaction in the EUR 39.05 area should help a rebound towards EUR 40.3. A trend line is one more argument in favor of a reversal movements towards the daily mid-term resistance. Moreover, technical indicators show a significant oversold condition which strengthens this bullish scenario.
So as to make the most of a potential technical rebound of Colruyt, it seems opportune to take a long position at the current price. A confirmation of this pattern would enable the security to reach the EUR 41.78 resistance. Investors should not insist under EUR 39.05 and are better of placing a stop loss order under this threshold.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.